Sanofi filed a complaint that alleged Seikagaku-developed and Zimmer-distributed Gel-One product infringed its patent for treating knee arthritis. A federal jury ruled last month that the patent includes administration through a single injection rather than multiple injections. The patent was also ruled invalid because it included “obvious variations of earlier work.”
More Articles on Orthopedic Devices:
14 Orthopedic & Spine Device Company Financial Reports
Smith & Nephew Looks for Merger or Acquisition Deal
Indian Market for Orthopedic Soft Tissue and Sports Medicine Devices Reached $17M in 2011
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
